Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin FR0000120578
Ticker SAN.PA
Company SANOFI
Currency €
Price
Aware Investor Index (AII) 0.6685
Recommendation BUY
P/E 19.71
ROE 8.68 %
Capitalization 116,880,419,991 $
Dividend Yield 3.83 %
P/S 2.92
AII Position 304
P/E Position 260
ROE Position 439
Capitalization Position 72
Dividend Yield Position 178
Sales 34,463,000,000 €
10-Year Average Earnings 5,109,200,000 €
Shares Outstanding 1,255,200,000
Equity 58,876,000,000 €
Dividend per Share 3.07 €
Industry Pharmaceutical
Country France
SANOFI Investor Relations Web Site http://en.sanofi.com/investors/investors.aspx







Sales:

YEAR MONTH AMOUNT
2018 12 34,463,000,000.00 €
2017 12 35,055,000,000.00 €
2016 12 33,821,000,000.00 €
2015 12 34,542,000,000.00 €
2014 12 31,694,000,000.00 €
2013 12 30,966,000,000.00 €

Earnings:

YEAR MONTH AMOUNT
2018 12 4,306,000,000.00 €
2017 12 8,416,000,000.00 €
2016 12 4,709,000,000.00 €
2015 12 4,287,000,000.00 €
2014 12 4,390,000,000.00 €
2013 12 3,717,000,000.00 €
2012 12 4,889,000,000.00 €
2011 12 5,646,000,000.00 €
2010 12 5,467,000,000.00 €
2009 12 5,265,000,000.00 €

Equity:

YEAR MONTH AMOUNT
2018 12 58,876,000,000.00 €
2017 12 58,089,000,000.00 €
2016 12 57,554,000,000.00 €
2015 12 58,210,000,000.00 €
2014 12 56,268,000,000.00 €
2013 12 57,014,000,000.00 €
2012 12 57,338,000,000.00 €
2011 12 56,203,000,000.00 €

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 1,255,200,000
2017 12 1,266,800,000
2016 12 1,296,000,000
2015 12 1,320,700,000
2014 12 1,331,100,000
2013 12 1,339,100,000
2012 12 1,319,500,000
2011 12 1,320,881,670

 












Bloomberg News for SANOFI:



Google News for SANOFI:

Citywire Financial Publishers - 3 Aug 2019
Lexicon setback raises further question mark over BioPharma dividend
... million) from BioPharma, have plunged 78% in the past week after French healthcare giant Sanofi (SAN.PA) terminated an agreement to help ...
Finanztrends - 13 Jul 2019
Die wichtigsten Aktien Europas geben am Dienstag ab – EURO ...
... teils deutliche Kursabschläge registriert; dagegen gewannen die Aktien von Daimler, Unilever und Sanofi zum Teil deutlich an Wert.
ecodiario - 3 Feb 2015
Sanofi lanza insulina inhalable para diabéticos
Desarrollado por Mannkind Corp, Afrezza será la únicainsulina inhalable en el mercado estadounidense, donde SANOFI (SAN.PA)ompite con ...
elEconomista.es - 22 Oct 2012
Coca-Cola se alía con Sanofi para vender en las farmacias
NY) será la encargada de formular y fabricar los productos y Sanofi (SAN.PA) se hará responsable de la distribución a las farmacias. La nueva ...
ecodiario - 24 Sep 2009
VaxGen, el chicharro que desarrolló uno de los componentes de la ...
El gigante farmaceútico francés Sanofi ha anunciado hoy en Tailandia ... desarrollada por Sanofi (SAN.PA), y AidsVax B/E, desarrollada en su ...


Back